Mechanisms of microglia-specific genetic variants associated with Alzheimer's disease
Bidragets beskrivning
Alzheimer's disease (AD), the main cause of dementia world-wide, is clinically manifested as memory impairment and executive dysfunction. Most of the pathomechanistic studies in AD have so far largely concentrated on neurons, neglecting the role of other brain cells in neurodegeneration. The goal of the MgAlz project is to elucidate microglial molecular mechanisms and regulatory pathways in AD by focusing on specific AD-associated genetic variants in PLCG2 and TREM2 genes and utilizing the latest research methodologies, mouse and human-based model systems and cohorts, PET imaging, multilevel omics, endophenotype analyses, and integrative bioinformatics to advance understanding of the role of microglia in AD. This new knowledge will advance identification of novel disease mechanisms and targets to be tested as personalized medicine-based biomarkers and therapeutic targets for AD.
Visa merStartår
2021
Slutår
2025
Beviljade finansiering
Övriga uppgifter
Finansieringsbeslutets nummer
338182
Vetenskapsområden
Neurovetenskaper
Forskningsområden
Molekyyli- ja solutason neurotiede
Identifierade teman
brain, neuroscience